your shopping cart is empty.
arrowrightCONTACT
Choose your country Choose your country

Worldwide:
T: +49-30-6392-7878
X: +49-30-6392-7888

USA /Canada:
T: 1.888.578.2660
X: 1.888.578.2666

E-Mail:
peptide@jpt.com

Contact

Content follows

CATALOG PRODUCT FINDER

SARS-CoV-2 Antigen Peptide NCAP (KMKDLSPRWYFYYLG)

SARS-CoV-2 Antigen Peptide NCAP (KMKDLSPRWYFYYLG)
Qty. Price
1 259,00 €
  
add to cart
 
 
 
Delivery in 2-5 days
Excluding tax
Prices do not include tax. For shipment within Germany 16% MwSt will be included at checkout and in the invoice. For shipment within EU-countries you will need to provide the valid VAT number. International customers should note that all duties, import fees, and taxes are to be paid by the customer
and
shipping fees
Combine this product with our corresponding SARS-CoV-2 Nucleoprotein Products: PepMix™ Peptide Pools, Antigen Peptides and RepliTope™ Peptide Microarrays.

SARS-CoV-2 Antigen Peptide NCAP (KMKDLSPRWYFYYLG)

Product Code: SP-WCPV-029

SARS-CoV-2 Antigen Peptide NCAP (KMKDLSPRWYFYYLG), probable allele specificity HLA class II, for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Amount: 1 vial containing 50 µg peptide
Purity: >90% (HPLC-MS)
Delivery Format: Freeze dried in plastic vials
Application(s): T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response
Indication(s)/Topic(s): Infection, Respiratory infection, Covid-19
Delivery Time: 2 - 5 days

JPT’s SARS-CoV-2 Antigen Peptides
Individual antigen peptides are derived from information on the human immune response towards SARS-virus, which is very similar to SARS-CoV-2. Sequences which are identical (28 peptides) or similar (13 peptides with one mutation, 7 with two and one with three) to experimentally confirmed SARS-epitopes are made available through our shop. These peptides can be used for antigen specific T-cell stimulation, T-cell assays or T-cell expansion. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.

Benefits of JPT’s Antigen Peptides
- Whole production performed in a regulated European environment according to DIN EN ISO 9001:2015 & GCLP standards; audits welcome!
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool and MHC Dextramer with your peptide as a set!

SARS-CoV-2 Antigen Peptide NCAP (KMKDLSPRWYFYYLG)

References:
Read References with Antigen Peptides

Description

Product Code: SP-WCPV-029

SARS-CoV-2 Antigen Peptide NCAP (KMKDLSPRWYFYYLG), probable allele specificity HLA class II, for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Amount: 1 vial containing 50 µg peptide
Purity: >90% (HPLC-MS)
Delivery Format: Freeze dried in plastic vials
Application(s): T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response
Indication(s)/Topic(s): Infection, Respiratory infection, Covid-19
Delivery Time: 2 - 5 days

JPT’s SARS-CoV-2 Antigen Peptides
Individual antigen peptides are derived from information on the human immune response towards SARS-virus, which is very similar to SARS-CoV-2. Sequences which are identical (28 peptides) or similar (13 peptides with one mutation, 7 with two and one with three) to experimentally confirmed SARS-epitopes are made available through our shop. These peptides can be used for antigen specific T-cell stimulation, T-cell assays or T-cell expansion. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.

Benefits of JPT’s Antigen Peptides
- Whole production performed in a regulated European environment according to DIN EN ISO 9001:2015 & GCLP standards; audits welcome!
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool and MHC Dextramer with your peptide as a set!

References

References:
Read References with Antigen Peptides

Documentation

Properties

News

Infectious diseases beyond COVID-19

JPT's peptide formats in the literature
(Oct 2020)
Read more

SARS COV-2 Mass Spec Reference Kit Released!:

SARS-CoV-2 SpikeMix  for Mass Spectrometry covers spike, NCAP, VME-1 & ORF9B
(July 2020)
Read more

New! SARS-CoV-2 Epitope Mapping Peptide Sets

Save time and samples and check our new SARS-CoV-2 Epitope Mapping Peptide Sets (EMPS).
(Apr 2020)
Read more


> Read more news!

Quality Assurance

All production is performed according to ISO 9001:2015 standards.

ISO 9001

 
Stay in touch and be the first to receive the latest news!

Contact us:

JPT Peptide Technologies GmbH
Volmerstrasse 5
12489 Berlin, Germany
Technical Support:
T: +49-30-6392-7878
X: +49-30-6392-7888
e-mail: peptide@jpt.com
USA & Canada:
T: 1.888.JPT.COM0 (1.888.578.2660)
X: 1.888.JPT.COM6 (1.888.578.2666)
e-mail: peptide@jpt.com